Pesquisar
NovaBay Pharmaceuticals Inc
NBYAdicionar à lista de desejos
1.950USD
0.0000.00%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
68.61MValor de mercado
PerdaP/L TTM
Mais detalhes de NovaBay Pharmaceuticals Inc Empresa
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Informações de NovaBay Pharmaceuticals Inc
Código da empresaNBY
Nome da EmpresaNovaBay Pharmaceuticals Inc
Data de listagemOct 26, 2007
CEOKazley (Michael John)
Número de funcionários14
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 26
Endereço2000 Powell St Ste 1150
CidadeEMERYVILLE
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal94608-1804
Telefone15108998800
Sitehttps://novabay.com/
Código da empresaNBY
Data de listagemOct 26, 2007
CEOKazley (Michael John)
Executivos da empresa NovaBay Pharmaceuticals Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de NovaBay Pharmaceuticals Inc?
Os cinco principais acionistas de NovaBay Pharmaceuticals Inc são: Ms. Swan Sit
Quantas instituições possuem ações da NovaBay Pharmaceuticals Inc (NBY)?
Em 2026Q1, 47 instituições possuíam ações da NovaBay Pharmaceuticals Inc, com valor de mercado aproximado de 1.80M, representando 6.77% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 1464094.00.